Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

A Validated and Licensed Method of Bone Marrow Aspirate Procurement to Support Advanced Therapy Investigational Medicinal Product (ATIMP) Manufacture

Sean Naughton, BSc, MSc, Veronica McInerney, PhD, Sara-Azhari Mohamed, MD, Sara Finnerty, Margaret Tarpey, BSc, MSc, Amjad Hayat, MBBS, MRCP, PhD FRCPath, Janusz Krawczyk, MD

Blood (2017) 130 (Supplement 1): 5460.

https://doi.org/10.1182/blood.V130.Suppl_1.5460.5460

Published: 2017

Journal Articles

Glycogen Synthase Kinase-3 (GSK3) Inhibition with Lithium in Combination with Tretinoin Induces Differentiation in Non-Promyelocytic Acute Myeloid Leukemia (AML)

Masumi Ueda, MD, Paolo F. Caimi, MD, Tammy Stefan, Hillard M. Lazarus, MD, Brenda Cooper, MD, Marcos de Lima, MD, Stanton L. Gerson, MD, David N. Wald, MDPhD

Blood (2015) 126 (23): 1360.

https://doi.org/10.1182/blood.V126.23.1360.1360

Published: 2015

Journal Articles

All -Trans-Retinoic Acid (ATRA) Combined with Lithium As Treatment of Relapsed Non-Progranulocytic AML: Therapeutic Targeting Inhibition of the Glycogen Synthase Kinase 3-Beta (GSK3) Enzyme

Paolo Caimi, MD, Kalpana Gupta, PhD, Tammy Stefan, Brenda Cooper, MD, Basem M. William, MD, Erica L Campagnaro, MD, Richard J. Creger, Pharm D, Donna Kane, BSN, Stanton L. Gerson, Hillard M. Lazarus, MD, Marcos de Lima, MD, David N. Wald, MD PhD

Blood (2014) 124 (21): 5299.

https://doi.org/10.1182/blood.V124.21.5299.5299

Published: 2014

Journal Articles

Cell Of Origin Does Not Affect Outcomes In Early Stage Non-Bulky Diffuse Large B-Cell Lymphoma Treated With Short-Course Combined Modality Therapy

Matthew A. Lunning, DO, Jocelyn C. Maragulia, BS, Anita Kumar, MD, Martin Bast, BS, Philip Bierman, MD, R. Gregory Bociek, MD, Julie M Vose, MD, MBA, James O. Armitage, MD, Steven M. Horwitz, MD, Andrew D Zelenetz, MD, PhD

Blood (2013) 122 (21): 3017.

https://doi.org/10.1182/blood.V122.21.3017.3017

Published: 2013

Journal Articles

Chronic Neutrophilia: A Risk Factor for VTE?.

Margarita Kushnir, MD, Hillel W Cohen, DrPH, MPH, Henny Heisler Billett, MD

Blood (2012) 120 (21): 2249.

https://doi.org/10.1182/blood.V120.21.2249.2249

Published: 2012

Journal Articles

Autophagy As a Target for Differentiation Therapy in Acute Myeloid Leukemia.

Nina M. Orfali, MBBchBAO, Tracey O'Donovan, PhD, Michelle Nyhan, PhD, Nigel P Mongan, PhD, Lorraine J Gudas, PhD, Mary R Cahill, MB FRCPath, Sharon McKenna, PhD

Blood (2012) 120 (21): 2464.

https://doi.org/10.1182/blood.V120.21.2464.2464

Published: 2012

Journal Articles

Lithium Treatment Potentiates Both in Vitro and in Vivo Retinoic Acid Efficacy in APL.

Fabien Zassadowski, PhD, Katka Pokorna, PhD, Nicolas Ferre, Laura Llopis, PharmD, Oussama Chourbagi, PhD, Joel Poupon, PharmD, Martine Chopin, Pierre Fenaux, MD, PhD, Rose Ann Padua, PhD, Marika Pla, PhD, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD, PhD

Blood (2012) 120 (21): 2614.

https://doi.org/10.1182/blood.V120.21.2614.2614

Published: 2012

Journal Articles

The combination of valproic acid and lithium delays hematopoietic stem/progenitor cell differentiation

Marta A. Walasek, Leonid Bystrykh, Vincent van den Boom, Sandra Olthof, Albertina Ausema, Martha Ritsema, Gerwin Huls, Gerald de Haan, Ronald van Os

Blood (2012) 119 (13): 3050–3059.

https://doi.org/10.1182/blood-2011-08-375386

Published: 2012

Includes: Supplemental data

Journal Articles

Pivotal Role for Gsk3 in Hematopoietic Stem Cell Homeostasis

Jian Huang, MD, PhD, Peter S. Klein, MD, PhD

Blood (2011) 118 (21): 1292.

https://doi.org/10.1182/blood.V118.21.1292.1292

Published: 2011

Journal Articles

Reversal of Heparin by Novel Synthetic Antagonist PMX-60056 Exhibits a Linear Dose-Response Relationship

R. Eric McAllister, MD, DPhil

Blood (2010) 116 (21): 3329.

https://doi.org/10.1182/blood.V116.21.3329.3329

Published: 2010

Journal Articles

Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia

Versha Banerji, MD, Kenneth N. Ross, PhD, Loretta S. Li, MD, Stacey M. Frumm, Anna C. Schinzel, PhD, Cynthia K. Hahn, Rose M. Kakoza, MD, Kwan T. Chow, Linda Ross, PhD, Haig Inguilizian, MD, Ilene Galinsky, ANP, Richard M Stone, MD, Daniel J DeAngelo, MD, PhD, William C. Hahn, MD, PhD, Andrew L. Kung, MD, PhD, Kimberly Stegmaier, MD

Blood (2010) 116 (21): 1000.

https://doi.org/10.1182/blood.V116.21.1000.1000

Published: 2010

Journal Articles

Chronic Idiopathic Neutrophilia: Retrospective Analysis of Causes and Consequences

Rafael Arteta-Bulos, Fellow, MD, Alva B. Weir, III, MD, FACP, James Lewis, MD

Blood (2010) 116 (21): 4717.

https://doi.org/10.1182/blood.V116.21.4717.4717

Published: 2010

Journal Articles

Novel Three– and Four–Drug Combinations of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Newly Diagnosed Multiple Myeloma: Encouraging Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study.

Shaji Kumar, Ian W. Flinn, Parameswaran N. Hari, Natalie Callander, Stephen J. Noga, A. Keith Stewart, Jonathan Glass, Noopur Raje, Robert M. Rifkin, Hongliang Shi, Iain J. Webb, Paul G. Richardson, S. Vincent Rajkumar

Blood (2009) 114 (22): 127.

https://doi.org/10.1182/blood.V114.22.127.127

Published: 2009

Journal Articles

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

Shaji Kumar, MD, Ian W Flinn, MD, PhD, Stephen J. Noga, MD, PhD, Parameswaran Hari, MD, MS, Robert M. Rifkin, MD, Natalie Scott Callander, MD, Manish Bhandari, MD, Jeffrey Lee Wolf, MD, Cristina Gasparetto, MD, Amrita Krishnan, MD, FACP, Daren D Grosman, MD, PhD, Jonathan Glass, MD, Entezam Asim Sahovic, MD, Hongliang Shi, MS, Iain J. Webb, MD, Paul Richardson, MD, S. Vincent Rajkumar, MD

Blood (2008) 112 (11): 93.

https://doi.org/10.1182/blood.V112.11.93.93

Published: 2008

Journal Articles

The Glycogensynthase Kinase 3b (GSK-3β) Is Involved in Leukemic Transformation

Jörg Bäsecke, Anneke Lehmann, Ulla Bergholz, James McCubrey, PhD, Lorenz Trümper, Carol Stocking, Stefan Horn

Blood (2008) 112 (11): 4489.

https://doi.org/10.1182/blood.V112.11.4489.4489

Published: 2008

Journal Articles

Evaluation of the Role of Flow Cytometry as a Diagnostic Tool for Hereditary Spherocytosis

Nalini K Pati, MBBS, MD, DNB, Mary M Sartor, BSc, Sue Wong, Adrienne Nemet, Kenneth Francis Bradstock, MB, FRACP, FRCPA, PhD

Blood (2008) 112 (11): 5381.

https://doi.org/10.1182/blood.V112.11.5381.5381

Published: 2008

Journal Articles

Intensive Versus Double Intensive Therapy in Untreated Multiple Myeloma: Final Analysis of the HOVON 24 Trial.

Pieter Sonneveld, MD, Bronno van der Holt, MSc, Edo Vellenga, MD, Sandra Croockewit, MD, Gregor Verhoef, MD, Christine Segeren, MD, Henk Lokhorst, MD

Blood (2005) 106 (11): 2545.

https://doi.org/10.1182/blood.V106.11.2545.2545

Published: 2005

Journal Articles

Inhibition of Wnt Pathway Signaling by Thalidomide and Revlimid: Studies in a Drosophila Model System.

A. Keith Stewart, MBCHB, Yuan Xiao Zhu, Maryan Yahyapour, Armen Manoukian, PhD, Sam E. Scanga

Blood (2004) 104 (11): 3356.

https://doi.org/10.1182/blood.V104.11.3356.3356

Published: 2004

Journal Articles

Band 3 Campinas: A Novel Splicing Mutation in the Band 3 Gene ( AE1 ) Associated With Hereditary Spherocytosis, Hyperactivity of Na + /Li + Countertransport and an Abnormal Renal Bicarbonate Handling

Paulo R.M. Lima, José A.R. Gontijo, José B. Lopes de Faria, Fernando F. Costa, Sara T.O. Saad

Blood (1997) 90 (7): 2810–2818.

https://doi.org/10.1182/blood.V90.7.2810

Published: 1997

Journal Articles

The effect of lithium on growth factor production in long-term bone marrow cultures

HE McGrath, CM Liang, TA Alberico, PJ Quesenberry

Blood (1987) 70 (4): 1136–1142.

https://doi.org/10.1182/blood.V70.4.1136.1136

Published: 1987

NARROW

A Validated and Licensed Method of Bone Marrow Aspirate Procurement to Support Advanced Therapy Investigational Medicinal Product (ATIMP) Manufacture

Glycogen Synthase Kinase-3 (GSK3) Inhibition with Lithium in Combination with Tretinoin Induces Differentiation in Non-Promyelocytic Acute Myeloid Leukemia (AML)

All -Trans-Retinoic Acid (ATRA) Combined with Lithium As Treatment of Relapsed Non-Progranulocytic AML: Therapeutic Targeting Inhibition of the Glycogen Synthase Kinase 3-Beta (GSK3) Enzyme

Cell Of Origin Does Not Affect Outcomes In Early Stage Non-Bulky Diffuse Large B-Cell Lymphoma Treated With Short-Course Combined Modality Therapy

Chronic Neutrophilia: A Risk Factor for VTE?.

Autophagy As a Target for Differentiation Therapy in Acute Myeloid Leukemia.

Lithium Treatment Potentiates Both in Vitro and in Vivo Retinoic Acid Efficacy in APL.

The combination of valproic acid and lithium delays hematopoietic stem/progenitor cell differentiation

Pivotal Role for Gsk3 in Hematopoietic Stem Cell Homeostasis

Reversal of Heparin by Novel Synthetic Antagonist PMX-60056 Exhibits a Linear Dose-Response Relationship

Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia

Chronic Idiopathic Neutrophilia: Retrospective Analysis of Causes and Consequences

Novel Three– and Four–Drug Combinations of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Newly Diagnosed Multiple Myeloma: Encouraging Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study.

Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

The Glycogensynthase Kinase 3b (GSK-3β) Is Involved in Leukemic Transformation

Evaluation of the Role of Flow Cytometry as a Diagnostic Tool for Hereditary Spherocytosis

Intensive Versus Double Intensive Therapy in Untreated Multiple Myeloma: Final Analysis of the HOVON 24 Trial.

Inhibition of Wnt Pathway Signaling by Thalidomide and Revlimid: Studies in a Drosophila Model System.

Band 3 Campinas: A Novel Splicing Mutation in the Band 3 Gene ( AE1 ) Associated With Hereditary Spherocytosis, Hyperactivity of Na + /Li + Countertransport and an Abnormal Renal Bicarbonate Handling

The effect of lithium on growth factor production in long-term bone marrow cultures

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only